Report #2847013

Overview

Sex

Male

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

solid tumor cancer; This serious case was reported by a consumer via interactive digital media and described the occurrence of malignant solid tumor in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced malignant solid tumor (Verbatim: solid tumor cancer) (serious criteria GSK medically significant). The outcome of the malignant solid tumor was not reported. It was unknown if the reporter considered the malignant solid tumor to be related to Shingrix. The company considered the malignant solid tumor to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 16-JUN-2025 This case was reported by a consumer via interactive digital media. The reporter reported the information on booster Shingrix series after 7 years for 80 years old male with solid tumor cancers and taking immunosuppressive drugs.; Sender's Comments: Neoplasm malignant is an unlisted event which is considered unrelated to GSK vaccine Shingrix.